Sarfati M, Rector E, Wong K, Rubio-Trujillo M, Sehon A H, Delespesse G
Immunology. 1984 Oct;53(2):197-205.
RPMI 8866 lymphoblastoid cells, known to express surface Fc epsilon R, were tested for their ability to regulate the in vitro synthesis of human IgE. Cell-free supernatants (CFS) of RPMI 8866 cells enhanced in a dose-dependent fashion the spontaneous IgE synthesis by B cells of allergic individuals. For maximum activity the CFS had to be added during the first 3 days of culture. CFS did not significantly alter the spontaneous synthesis of IgM or IgG, but they suppressed IgA synthesis both in B cell cultures and in pokeweed mitogen-stimulated peripheral blood mononuclear cells cultures. Cyclosporin A did not suppress either the spontaneous Ig production by B cells nor the IgE-potentiating activity of CFS. The enhancing activity of CFS was related to its content in IgE binding factors (IgE-BFs); these factors were detected by their ability to inhibit the rosetting of RPMI 8866 cells with IgE-coated erythrocytes (E-IgE). Both the IgE-BFs and the IgE-potentiating activity of the supernatants of RPMI 8866 cell cultures could be removed by absorption with IgE-Sepharose, from which they could subsequently be eluted with glycine-HCl buffer. IgE-BFs were identified as glycoproteins on the basis of their sensitivity to trypsin and to neuraminidase. By filtration of the RPMI 8866 cell supernatants through a Sephadex G75 column, IgE-binding activity was found to be associated with two fractions with molecular sizes in the range of 10,000-15,000 and 30,000-40,000. The IgA-suppressing activity of the RPMI 8866 culture filtrates could be absorbed with sIgA-Sepharose from which it was subsequently recovered by elution with glycine-HCl buffer. Most unexpectedly, sIgA-Sepharose also removed IgE-BFs and IgE-potentiating activity from the RPMI 8866 supernatants; both could be recovered by subsequent elution from sIgA-Sepharose with gycline-HCl buffer. These data are provisionally interpreted as indicating that the IgE-BFs secreted by RPMI 8866 cells had affinity for both IgE and sIgA and that they exerted a reciprocal effect on the in vitro synthesis of IgE and IgA.
已知表达表面FcεR的RPMI 8866淋巴母细胞被检测其调节人IgE体外合成的能力。RPMI 8866细胞的无细胞上清液(CFS)以剂量依赖性方式增强了过敏个体B细胞的自发IgE合成。为了达到最大活性,必须在培养的前3天添加CFS。CFS没有显著改变IgM或IgG的自发合成,但它们在B细胞培养物和商陆有丝分裂原刺激的外周血单个核细胞培养物中均抑制IgA合成。环孢素A既不抑制B细胞的自发Ig产生,也不抑制CFS的IgE增强活性。CFS的增强活性与其IgE结合因子(IgE-BFs)的含量有关;这些因子通过其抑制RPMI 8866细胞与IgE包被的红细胞(E-IgE)形成花环的能力来检测。RPMI 8866细胞培养物上清液中的IgE-BFs和IgE增强活性都可以用IgE-琼脂糖吸附去除,随后可以用甘氨酸-HCl缓冲液从其中洗脱。基于其对胰蛋白酶和神经氨酸酶的敏感性,IgE-BFs被鉴定为糖蛋白。通过Sephadex G75柱过滤RPMI 8866细胞上清液,发现IgE结合活性与分子大小在10,000 - 15,000和30,000 - 40,000范围内的两个组分相关。RPMI 8866培养滤液的IgA抑制活性可以用分泌型IgA-琼脂糖吸附,随后用甘氨酸-HCl缓冲液洗脱回收。最出乎意料的是,分泌型IgA-琼脂糖也从RPMI 8866上清液中去除了IgE-BFs和IgE增强活性;两者都可以通过随后用甘氨酸-HCl缓冲液从分泌型IgA-琼脂糖中洗脱回收。这些数据初步解释为表明RPMI 8866细胞分泌的IgE-BFs对IgE和分泌型IgA都有亲和力,并且它们对IgE和IgA的体外合成产生相互作用。